{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:37:10Z","timestamp":1773830230788,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jamda.2024.105113","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T20:21:26Z","timestamp":1719433286000},"page":"105113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antipsychotic Discontinuation and New Trazodone Use in Ontario Nursing Homes: Evidence of Medication Substitution"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7373","authenticated-orcid":false,"given":"Daniel A.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Maclagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Pequeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Iaboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen J.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Bronskill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105113_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare & Medicaid Services\u2019 national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105113_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bmjqs-2018-007840","article-title":"Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses","volume":"28","author":"Ivers","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jamda.2024.105113_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jamda.2021.12.043","article-title":"Potential unintended consequences of antipsychotic reduction in Ontario nursing homes","volume":"23","author":"Harris","year":"2022","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105113_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jamda.2020.05.039","article-title":"Trends in antipsychotic and mood stabilizer prescribing in long-term care in the U.S.: 2011-2014","volume":"21","author":"Gerlach","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105113_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/appi.ajp.21060591","article-title":"Evaluation of antipsychotic reduction efforts in patients with dementia in veterans health administration nursing homes","volume":"179","author":"Gerlach","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2024.105113_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40266-021-00875-1","article-title":"What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? A qualitative systematic review of barriers and facilitators","volume":"38","author":"Moth","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2024.105113_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2018.01.170230","article-title":"Primary care physician perspectives about antipsychotics and other medications for symptoms of dementia","volume":"31","author":"Kerns","year":"2018","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.jamda.2024.105113_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13607863.2016.1277974","article-title":"Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care","volume":"22","author":"Olivieri-Mui","year":"2018","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2024.105113_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008191.pub2","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2024.105113_bib10","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/jgs.15519","article-title":"Low-dose trazodone, benzodiazepines, and fall-related Injuries in nursing homes: a matched-cohort study","volume":"66","author":"Bronskill","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105113_bib11","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1503\/cmaj.180551","article-title":"Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study","volume":"190","author":"Watt","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jamda.2024.105113_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MLR.0000000000001814","article-title":"Variation and correlation of potential unintended consequences of antipsychotic reduction in Ontario nursing homes over time","volume":"61","author":"Harris","year":"2023","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2024.105113_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-016-0380-3","article-title":"Changing pattern of sedative use in older adults: a population-based cohort study","volume":"33","author":"Iaboni","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2024.105113_bib14","doi-asserted-by":"crossref","first-page":"M174","DOI":"10.1093\/geronj\/49.4.M174","article-title":"MDS cognitive performance scale","volume":"49","author":"Morris","year":"1994","journal-title":"J\u00a0Gerontol"},{"key":"10.1016\/j.jamda.2024.105113_bib15","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/j.1532-5415.2008.02048.x","article-title":"The aggressive behavior scale: a new scale to measure aggression based on the minimum data set","volume":"56","author":"Perlman","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105113_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ageing\/29.2.165","article-title":"Development of a minimum data set-based depression rating scale for use in nursing homes","volume":"29","author":"Burrows","year":"2000","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105113_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40266-020-00799-2","article-title":"Sex differences in antipsychotic and benzodiazepine prescribing patterns: a cohort study of newly admitted nursing home residents with dementia in Ontario, Canada","volume":"37","author":"Maclagan","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2024.105113_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jpm.12488","article-title":"An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses","volume":"25","author":"Phillips","year":"2018","journal-title":"J\u00a0Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.jamda.2024.105113_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jagp.2023.01.022","article-title":"Changes in the initiation of antipsychotics and trazodone over time: a cohort study of new admissions to nursing homes in Ontario, Canada","volume":"31","author":"Harris","year":"2023","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105113_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18441","article-title":"Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada","volume":"4","author":"Campitelli","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024005358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024005358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:42:47Z","timestamp":1728384167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024005358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1525861024005358"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105113","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic Discontinuation and New Trazodone Use in Ontario Nursing Homes: Evidence of Medication Substitution","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105113"}}